Header cover image

Australian (ASX) Biotech Industry Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies39
  • 7D1.7%
  • 3M2.0%
  • 1Y-6.8%
  • YTD-1.9%

Over the last 7 days, the Biotech industry has risen 1.7%, driven by gains from CSL of 1.8%. In the same time, AVITA Medical was down 11%. However, the industry is down 6.8% over the past year. As for the next few years, earnings are expected to grow by 16% per annum.

Industry Valuation and Performance

Has the Australian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 28 Nov 2022AU$153.1bAU$15.9bAU$2.5b43.5x60.3x9.6x
Wed, 26 Oct 2022AU$141.3bAU$17.0bAU$2.7b40.7x51.6x8.3x
Fri, 23 Sep 2022AU$143.2bAU$16.1bAU$2.6b42.7x55.5x8.9x
Sun, 21 Aug 2022AU$149.8bAU$15.6bAU$2.7b41.8x55.7x9.6x
Tue, 19 Jul 2022AU$151.4bAU$15.8bAU$2.9b38.3x52.9x9.6x
Thu, 16 Jun 2022AU$131.3bAU$15.7bAU$2.8b32.7x46.3x8.4x
Sat, 14 May 2022AU$141.2bAU$15.7bAU$2.9b37x49.2x9x
Mon, 11 Apr 2022AU$135.2bAU$14.4bAU$2.6b38.5x51.7x9.4x
Wed, 09 Mar 2022AU$127.5bAU$14.7bAU$2.7b39.8x47.9x8.7x
Fri, 04 Feb 2022AU$133.2bAU$14.7bAU$2.8b37x47.6x9.1x
Sun, 02 Jan 2022AU$150.9bAU$14.4bAU$2.7b40.6x55.1x10.5x
Tue, 30 Nov 2021AU$152.1bAU$14.7bAU$2.8b41.9x54.3x10.3x
Thu, 28 Oct 2021AU$148.8bAU$14.0bAU$2.6b43.1x56.7x10.7x
Sat, 25 Sep 2021AU$155.1bAU$14.4bAU$2.7b43.7x57.3x10.8x
Mon, 23 Aug 2021AU$150.7bAU$14.0bAU$2.6b44.1x57.4x10.8x
Sat, 10 Jul 2021AU$141.3bAU$14.0bAU$2.6b41x53.8x10.1x
Fri, 02 Apr 2021AU$129.4bAU$13.5bAU$2.8b36.4x45.7x9.6x
Mon, 04 Jan 2021AU$137.1bAU$13.1bAU$3.0b37.3x45.9x10.5x
Thu, 08 Oct 2020AU$139.6bAU$13.5bAU$2.9b32.9x48.6x10.3x
Wed, 01 Jul 2020AU$137.4bAU$13.4bAU$2.7b42.8x51.4x10.2x
Sat, 04 Apr 2020AU$139.4bAU$14.9bAU$3.0b40.2x46.8x9.3x
Tue, 07 Jan 2020AU$131.9bAU$12.9bAU$2.5b43.8x52.5x10.2x
Price to Earnings Ratio

52.6x


Total Market Cap: AU$135.4bTotal Earnings: AU$2.6bTotal Revenue: AU$13.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Australian Biotech Industry Price to Earnings3Y Average 51.3x202020212022
Current Industry PE
  • Investors are optimistic on the Australian Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 60.3x which is higher than its 3-year average PE of 51.3x.
  • The industry is trading close to its 3-year average PS ratio of 9.9x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 6.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Australian Healthcare industry?

AU Market1.17%
Healthcare1.53%
Biotech1.73%
Biotech1.73%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CSL CSLAU$299.721.8%
+AU$2.6b
-3.9%PE43.2x
TLX Telix PharmaceuticalsAU$7.374.4%
+AU$97.5m
6.2%PS80.7x
MSB MesoblastAU$1.018.6%
+AU$58.9m
-40.8%PS61.8x
IMM ImmutepAU$0.336.6%
+AU$17.6m
-33.7%PS60.6x
ARX Aroa BiosurgeryAU$1.074.4%
+AU$15.4m
-8.2%PS9.9x
Simply Wall St™
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

AVH

AU$1.95

AVITA Medical

7D

-11.4%

1Y

-52.3%

MSB

AU$1.01

Mesoblast

7D

8.6%

1Y

-40.8%

RAC

AU$2.13

Race Oncology

7D

-4.5%

1Y

-35.8%

NSB

AU$0.12

NeuroScientific Biopharmaceuticals

7D

25.0%

1Y

-64.7%

CSL

AU$299.72

CSL

7D

1.8%

1Y

-3.9%

TLX

AU$7.37

Telix Pharmaceuticals

7D

4.4%

1Y

6.2%

PAR

AU$1.47

Paradigm Biopharmaceuticals

7D

-4.9%

1Y

-34.0%

PYC

AU$0.074

PYC Therapeutics

7D

2.8%

1Y

-49.0%

OPT

AU$0.96

Opthea

7D

-1.0%

1Y

-20.7%

IMU

AU$0.18

Imugene

7D

-2.7%

1Y

-64.7%

IMM

AU$0.33

Immutep

7D

6.6%

1Y

-33.7%

BNO

AU$0.06

Bionomics

7D

-6.3%

1Y

-53.8%

ACW

AU$0.12

Actinogen Medical

7D

-4.0%

1Y

-11.1%